Drug details

Onpattro (patisiran lipid complex injection)

type of RNAi Agents

Onpattro (patisiran) contains a transthyretin-directed small interfering RNA and is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• lightheadedness,
• fast heartbeats,
• dizziness,
• headache,
• chest pain or pressure
• warmth,
• severe dizziness,
• stomach pain, and

The following drugs are related to Onpattro, either as a replacement or used together:

• Abelcet (amphotericin b injection)
• Ambisome (amphotericin b)
• Amvuttra (vutrisiran injection)
• Tegsedi (inotersen injection)